Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

Mainak Majumder, Asish K. Ghosh, Robert Steele, Xiao Yan Zhou, Nancy J. Phillips, Ranjit Ray, Ratna B. Ray

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may lead to the development of hepatocellular carcinoma. However, the mechanism of development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. In the present study, we have investigated the effect of nonstructural protein 5A (NS5A) on TNF- and Fas-mediated apoptosis in the liver of transgenic mice. For this purpose, transgenic mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a detectable histological change in the liver at 8-12 weeks of age. Intraperitoneal injection of recombinant TNF induced hepatic injury and apoptosis in normal mice. In contrast, transgenic mice expressing NS5A protein were protected against hepatic apoptosis after injection of TNF. However, injection of anti-Fas antibody into transgenic mice did not significantly influence hepatic apoptosis compared to the normal littermates. These results suggested distinct effects of TNF and anti-Fas antibody in transgenic mice expressing NS5A. We subsequently investigated the effect of NS5A in signaling pathways involved in these two cytokine-mediated apoptosis. A physical association between NS5A and TRADD was observed by pull-down assay, coimmunoprecipitation, and colocalization experiments. Furthermore, NS5A prevented the association between TRADD and FADD and blocked TRADD-mediated NF-κB activation. Together, our results suggest that NS5A impairs TNF-mediated apoptosis by interfering upstream of the signal transduction pathway and may play a role in HCV-mediated pathogenesis.

Original languageEnglish (US)
Pages (from-to)94-105
Number of pages12
JournalVirology
Volume294
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Transgenic Mice
Anti-Idiotypic Antibodies
Apoptosis
Liver
Hepacivirus
Proteins
Chronic Hepatitis
TNF Receptor-Associated Death Domain Protein
Genetically Modified Animals
Injections
Apolipoproteins E
hepatitis C virus NS-5 protein
Intraperitoneal Injections
Hepatocellular Carcinoma
Signal Transduction
Cytokines
Wounds and Injuries

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Majumder, M., Ghosh, A. K., Steele, R., Zhou, X. Y., Phillips, N. J., Ray, R., & Ray, R. B. (2002). Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology, 294(1), 94-105. https://doi.org/10.1006/viro.2001.1309

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. / Majumder, Mainak; Ghosh, Asish K.; Steele, Robert; Zhou, Xiao Yan; Phillips, Nancy J.; Ray, Ranjit; Ray, Ratna B.

In: Virology, Vol. 294, No. 1, 2002, p. 94-105.

Research output: Contribution to journalArticle

Majumder, M, Ghosh, AK, Steele, R, Zhou, XY, Phillips, NJ, Ray, R & Ray, RB 2002, 'Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice', Virology, vol. 294, no. 1, pp. 94-105. https://doi.org/10.1006/viro.2001.1309
Majumder, Mainak ; Ghosh, Asish K. ; Steele, Robert ; Zhou, Xiao Yan ; Phillips, Nancy J. ; Ray, Ranjit ; Ray, Ratna B. / Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. In: Virology. 2002 ; Vol. 294, No. 1. pp. 94-105.
@article{41d000b4ee044979a51f101dd0946d42,
title = "Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice",
abstract = "Hepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may lead to the development of hepatocellular carcinoma. However, the mechanism of development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. In the present study, we have investigated the effect of nonstructural protein 5A (NS5A) on TNF- and Fas-mediated apoptosis in the liver of transgenic mice. For this purpose, transgenic mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a detectable histological change in the liver at 8-12 weeks of age. Intraperitoneal injection of recombinant TNF induced hepatic injury and apoptosis in normal mice. In contrast, transgenic mice expressing NS5A protein were protected against hepatic apoptosis after injection of TNF. However, injection of anti-Fas antibody into transgenic mice did not significantly influence hepatic apoptosis compared to the normal littermates. These results suggested distinct effects of TNF and anti-Fas antibody in transgenic mice expressing NS5A. We subsequently investigated the effect of NS5A in signaling pathways involved in these two cytokine-mediated apoptosis. A physical association between NS5A and TRADD was observed by pull-down assay, coimmunoprecipitation, and colocalization experiments. Furthermore, NS5A prevented the association between TRADD and FADD and blocked TRADD-mediated NF-κB activation. Together, our results suggest that NS5A impairs TNF-mediated apoptosis by interfering upstream of the signal transduction pathway and may play a role in HCV-mediated pathogenesis.",
author = "Mainak Majumder and Ghosh, {Asish K.} and Robert Steele and Zhou, {Xiao Yan} and Phillips, {Nancy J.} and Ranjit Ray and Ray, {Ratna B.}",
year = "2002",
doi = "10.1006/viro.2001.1309",
language = "English (US)",
volume = "294",
pages = "94--105",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

AU - Majumder, Mainak

AU - Ghosh, Asish K.

AU - Steele, Robert

AU - Zhou, Xiao Yan

AU - Phillips, Nancy J.

AU - Ray, Ranjit

AU - Ray, Ratna B.

PY - 2002

Y1 - 2002

N2 - Hepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may lead to the development of hepatocellular carcinoma. However, the mechanism of development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. In the present study, we have investigated the effect of nonstructural protein 5A (NS5A) on TNF- and Fas-mediated apoptosis in the liver of transgenic mice. For this purpose, transgenic mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a detectable histological change in the liver at 8-12 weeks of age. Intraperitoneal injection of recombinant TNF induced hepatic injury and apoptosis in normal mice. In contrast, transgenic mice expressing NS5A protein were protected against hepatic apoptosis after injection of TNF. However, injection of anti-Fas antibody into transgenic mice did not significantly influence hepatic apoptosis compared to the normal littermates. These results suggested distinct effects of TNF and anti-Fas antibody in transgenic mice expressing NS5A. We subsequently investigated the effect of NS5A in signaling pathways involved in these two cytokine-mediated apoptosis. A physical association between NS5A and TRADD was observed by pull-down assay, coimmunoprecipitation, and colocalization experiments. Furthermore, NS5A prevented the association between TRADD and FADD and blocked TRADD-mediated NF-κB activation. Together, our results suggest that NS5A impairs TNF-mediated apoptosis by interfering upstream of the signal transduction pathway and may play a role in HCV-mediated pathogenesis.

AB - Hepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may lead to the development of hepatocellular carcinoma. However, the mechanism of development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. In the present study, we have investigated the effect of nonstructural protein 5A (NS5A) on TNF- and Fas-mediated apoptosis in the liver of transgenic mice. For this purpose, transgenic mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a detectable histological change in the liver at 8-12 weeks of age. Intraperitoneal injection of recombinant TNF induced hepatic injury and apoptosis in normal mice. In contrast, transgenic mice expressing NS5A protein were protected against hepatic apoptosis after injection of TNF. However, injection of anti-Fas antibody into transgenic mice did not significantly influence hepatic apoptosis compared to the normal littermates. These results suggested distinct effects of TNF and anti-Fas antibody in transgenic mice expressing NS5A. We subsequently investigated the effect of NS5A in signaling pathways involved in these two cytokine-mediated apoptosis. A physical association between NS5A and TRADD was observed by pull-down assay, coimmunoprecipitation, and colocalization experiments. Furthermore, NS5A prevented the association between TRADD and FADD and blocked TRADD-mediated NF-κB activation. Together, our results suggest that NS5A impairs TNF-mediated apoptosis by interfering upstream of the signal transduction pathway and may play a role in HCV-mediated pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0036063623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036063623&partnerID=8YFLogxK

U2 - 10.1006/viro.2001.1309

DO - 10.1006/viro.2001.1309

M3 - Article

C2 - 11886269

AN - SCOPUS:0036063623

VL - 294

SP - 94

EP - 105

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -